Since there is a partial overlap between CD44+/CD24+/ESA+ and CD133+ pancreatic cancer cells [6], it is conceivable that a combination of the markers may help to mark more pure CSCs than a single marker. This evidence concerns the gene CD44 and pancreatic neoplasm.